Cleared Traditional

K222789 - VADER® Pedicle System, G21 Cement (FDA 510(k) Clearance)

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K222789 · Icotec AG · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2023
Decision
116d
Days
Class 2
Risk

K222789 is an FDA 510(k) clearance for the VADER® Pedicle System, G21 Cement. Classified as Bone Cement, Posterior Screw Augmentation (product code PML), Class II - Special Controls.

Submitted by Icotec AG (9450 Altstaetten (Sg), CH). The FDA issued a Cleared decision on January 9, 2023 after a review of 116 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3027 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Icotec AG devices

Submission Details

510(k) Number K222789 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 15, 2022
Decision Date January 09, 2023
Days to Decision 116 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 122d · This submission: 116d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code PML Bone Cement, Posterior Screw Augmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3027
Definition The Device Is Intended To Augment The Fixation Of Screws In A Posterior Spinal System Construct.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Mcra, LLC
Justin Eggleton

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - PML Bone Cement, Posterior Screw Augmentation

All 17
Devices cleared under the same product code (PML) and FDA review panel - the closest regulatory comparables to K222789.
OLYMPIC Posterior Spinal Fixation System
K252885 · Astura Medical · Jan 2026
Meta+ Bone Cement & M.U.S.T. Fenestrated Pedicle Screw System
K241034 · Medacta International S.A. · Jun 2024
Momentum® Posterior Spinal Fixation System with G21 V-STEADY Bone Cement
K231809 · Ulrich Medical USA · Oct 2023
PERLA® TL System
K230774 · Spineart · Jun 2023
Invictus® Bone Cement, Invictus Spinal Fixation System
K221926 · Alphatec Spine, Inc. · Dec 2022
BonOs® Inject Bone Cement
K222256 · Neo Medical SA · Aug 2022